Alkem launches Drug for Epilepsy treatment in India

Alkem has launched Perampil, at 2 mg - Rs. 49/strip of 7 tablets, 4 mg - Rs. 180/strip of 15 tablets and 6 mg - Rs. 300/strip of 15 tablets, to improve patient access.

159
Alkem launches Drug for Epilepsy treatment in India

Last Updated on June 13, 2021 by The Health Master

Alkem Laboratories Ltd, one of the India’s leading pharmaceutical formulation development, manufacturing, and marketing companies, announces the launch of Perampil (perampanel) tablets 2 mg/4 mg/6 mg to make the treatment accessible to patients and healthcare providers improving their quality of life.

Alkem has launched Perampil, at 2 mg – Rs. 49/strip of 7 tablets, 4 mg – Rs. 180/strip of 15 tablets and 6 mg – Rs. 300/strip of 15 tablets, to improve patient access.

This product reaffirms Alkem’s commitment towards improving epilepsy care by bringing multiple treatment options of quality products to patients and health care professionals in India. Alkem had also launched Brivasure (brivaracetam) tablets in March 2021 for the adjunctive management of partial onset seizure with or without secondary generalization.

The drug, perampanel, has been approved by the Drugs Controller General of India (DCGI), as an adjunctive therapy in treatment of partial onset seizures in patients with epilepsy aged 4 years and older and also as an adjunctive therapy in treatment of primary generalized tonic-clonic seizures in patients with epilepsy aged 12 years and older.

Alkem continues to work persistently towards the production of top-quality products to improve patient access and quality of life for them.

Black Fungus: Mankind Pharma launches drug for treatment

Fake medicines used in C-19 treatment seized

Thousands of fake Online Pharmacies shut in global sting: Interpol

Rapid Microbiological testing lab brings down testing time from 14 days…

CSIR-IICT, Lee Pharma sign agreement to produce 2-D

Hospital in controversy to be sealed, patients being shifted

IPC to roll out various training Programmes for stake holders

Hybrid Multiply Face Masks: An Alternative to N95 Respirator

Kids below 18: Govt issues guidelines for management of black fungus

Black Fungus: Mankind Pharma launches drug for treatment

CSIR-IICT, Lee Pharma sign agreement to produce 2-D

Rapid Microbiological testing lab brings down testing time from 14 days…

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news